Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Protalix BioTherapeutics And 2 Other Penny Stocks Insiders Are Buying

Author: Lisa Levin | October 23, 2023 08:55am

The Dow Jones closed lower by around 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Tecogen

  • The Trade: Tecogen Inc. (OTC:TGEN) Director Susan B Hirsch acquired a total of 5,000 shares an average price of $0.92. To acquire these shares, it cost around 4,575.
  • What’s Happening: Tecogen announced the signing of a $1.5 million Credit Agreement.
  • What Tecogen Does: Tecogen Inc, designs, manufactures, markets, and maintains high efficiency, ultra-clean cogeneration products. It operates in three business segments, namely Products, Services and Energy Production.

Protalix BioTherapeutics

  • The Trade: Protalix BioTherapeutics, Inc. (NYSE:PLX) President and CEO Dror Bashan acquired a total of 64,516 shares at an average price of $1.40. To acquire these shares, it cost around $90,484.
  • What’s Happening: Protalix BioTherapeutics said operations have not been adversely affected by current security situation in Israel.
  • What Protalix BioTherapeutics Does: Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease.

Check This Out: Top 4 Health Care Stocks That May Rocket Higher This Month

Butler National

  • The Trade: Butler National Corporation (OTC:BUKS) 10% owner Joseph Patrick Daly acquired a total of 20,000 shares at an average price of $0.61. The insider spent $12,100 to buy those shares.
  • What’s Happening: Butler National disclosed the acquisition of KC Machine, a recognized provider of high-quality precision machine parts.
  • What Butler National Does: Butler National Corp is engaged in designing, manufacturing and selling, installing, repairing, modifying, overhauling, servicing and distributing a broad portfolio of aerostructures, aircraft components, avionics, accessories, subassemblies, and systems.

Don’t forget to check out our premarket coverage here

Posted In: BUKS PLX TGEN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist